基于真实世界证据的聚氨酯材质PICC导管带量采购后临床应用评价研究

刘伟, 耿姣姣, 杨文勇, 邓刚

中国医疗设备 ›› 2025, Vol. 40 ›› Issue (3) : 120-125.

PDF(1655 KB)
PDF(1655 KB)
中国医疗设备 ›› 2025, Vol. 40 ›› Issue (3) : 120-125. DOI: 10.3969/j.issn.1674-1633.20240987
研究论著

基于真实世界证据的聚氨酯材质PICC导管带量采购后临床应用评价研究

  • 刘伟, 耿姣姣, 杨文勇, 邓刚
作者信息 +

Evaluation of Clinical Application of Polyurethane PICC Catheter After Volume-Based Procurement Based on Real-World Evidence

  • LIU Wei, GENG Jiaojiao, YANG Wenyong, DENG Gang
Author information +
文章历史 +

摘要

目的 对比经外周静脉穿刺置入中心静脉导管(Peripherally Inserted Central Catheter,PICC)带量采购前后的临床使用情况及患者治疗费用,为优化临床决策、完善医用耗材带量采购政策提供参考。方法 通过关键知情人访谈收集PICC带量采购前后的临床使用情况,基于文献回顾、关键知情人访谈等构建PICC整体费用模型,采用Kruskal-Wallis检验对患者整体治疗费用进行分析。结果 通过护士访谈,带量后的PICC实际平均留置时间相较于带量前平均留置时间缩短10.77%、穿刺时间增加14.21%、置管后导致的并发症或不良反应发生率相对带量前均有不同程度的上升;PICC带量采购前后患者的住院费用、卫材费差异均有统计学意义(P<0.05)。带量采购后的PICC单价和均次置管总费用明显下降,但均次并发症费用呈上升趋势,差异均有统计学意义(P<0.05)。结论 带量采购后,PICC的质量及临床使用情况并不十分理想。建议各医疗主体加强对医用耗材带量采购前、中、后的质量评估体系建设和临床使用监测,系统分析患者治疗费用,逐步建立针对医用耗材带量采购的质量和整体费用评价标准,进一步完善医用耗材带量采购体系。

Abstract

ObjectiveTo compare the clinical use and the cost of patient treatment before and after the volume-based procurement of peripherally inserted central catheter (PICC), to provide a reference for optimizing clinical decision-making and improving the policy of volume-based procurement for medical consumables. Methods The clinical use data of PICC before and after volume-based procurement was collected through interviews with key insiders. The overall cost model of PICC was constructed based on literature review and interviews with key insiders. Kruskal-Wallis test was used to analyze the overall treatment cost of patients. Results According to the interviews with nurses, the actual mean retention time of PICC after volume-based procurement was reduced by 10.77%, the puncture time was increased by 14.21%, and the incidence of complications or adverse reactions caused by catheterization after volume-based procurement was increased to varying degrees compared with that before the volume-based procurement. There were statistically significant differences in hospitalization cost and eisai cost before and after the volume-based procurement of PICC ((P<0.05)). The unit price of PICC and the total cost of average catheterization after volume-based procurement decreased significantly, but the average cost of complications after volume-based procurement showed an increasing trend, with all the differences were statistically significant (P<0.05). Conclusion The quality and clinical use of PICC were not very satisfactory after the volume-based procurement. It is suggested that all medical entities strengthen the construction of quality evaluation system and clinical use monitoring before, during and after the volume-based procurement of medical consumables, systematically analyze the treatment costs of patients, gradually establish the quality and overall cost evaluation standards for the volume-based procurement of medical consumables, and further improve the volume-based procurement system of medical consumables.

关键词

经外周静脉穿刺置入中心静脉导管;带量采购;成本分析;并发症发生率;医用耗材;治疗费用结构

Key words

peripherally inserted central catheter (PICC); volume-based procurement; cost analysis; complication rate; medical consumables; treatment cost structure

引用本文

导出引用
刘伟, 耿姣姣, 杨文勇, . 基于真实世界证据的聚氨酯材质PICC导管带量采购后临床应用评价研究[J]. 中国医疗设备, 2025, 40(3): 120-125 https://doi.org/10.3969/j.issn.1674-1633.20240987
LIU Wei, GENG Jiaojiao, YANG Wenyong, et al. Evaluation of Clinical Application of Polyurethane PICC Catheter After Volume-Based Procurement Based on Real-World Evidence[J]. China Medical Devices, 2025, 40(3): 120-125 https://doi.org/10.3969/j.issn.1674-1633.20240987
中图分类号: R197.3   

参考文献

[1] Hadaway L. Short peripheral intravenous catheters and infections[J]. J Infus Nurs, 2012, 35(4): 230-240.
[2] Johansson E, Hammarskj?ld F, Lundberg D, et al. Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: a systematic review of the literature[J]. Acta Oncol, 2013, 52(5): 886-892.
[3] Wang G, Li Y, Wu C, et al. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: a prospective study[J]. Medicine (Baltimore), 2020, 99(12): e19409.
[4] 李美和, 关云娇, 赵翠兰. PICC在乳腺癌化疗中与CVC的优 势比较分析[J]. 中国现代药物应用, 2019, 13(13): 51-52.
[5] 李梅. 外周静脉置入中心静脉导管在恶性肿瘤患者中的应用 研究[J]. 中国社区医师, 2020, 36(16): 165.
Li M. Study on the application of peripherally inserted central venous catheter in patients with malignant tumor[J]. Chin Community Dr, 2020, 36(16): 165.
[6] Luo NT, Yue JY, Zhou RJ, et al. The effects of the national drug pooled procurement (NDPP) pilot program in China[J]. J Chin Pharm Sci, 2022, 3l(3): 212-217.
[7] Chen L, Yang Y, Luo M, et al. The impacts of national centralized drug procurement policy on drug utilization and drug expenditures: the case of Shenzhen, China[J]. Int J Environ Res Public Health, 2020, 17(24): 9415.
[8] 汤少梁, 陈蕾, 成彦. 国家药品集中带量采购政策对住院患者 医疗费用的影响研究[J]. 中国卫生经济, 2024, 43(1): 38-43.
Tang SL, Chen L, Cheng Y. A study on the impact of national volume-based procurement on inpatient medical costs[J]. Chin Health Econ, 2024, 43(1): 38-43.
[9] Chen YL, Ji X, Xiao H, et al. Impact of the pilot volumebased drug purchasing policy in China: interrupted time-series analysis with controls[J]. Front Pharmacol, 2021(12): 804237.
[10] 胡红岩, 穆耕林, 曹红梅, 等. 药品集中带量采购对糖尿病患 者住院费用的影响[J]. 中国卫生资源, 2023, 26(2): 163-166.
[11] 国务院办公厅. 关于印发治理高值医用耗材改革方案的通 知[EB/OL]. (2019-07-19)[2024-10-23]. https://www.gov.cn/ gongbao/content/2019/content_5421542.htm.
[12] 国家医疗保障局. 关于国家组织冠脉支架集中带量采 购和使用配套措施的意见[EB/OL]. (2020-12-15)[2024- 10-23]. https://www.gov.cn/zhengce/zhengceku/2020-12/17/ content_5570425.htm.
[13] 国家医保局, 国家发展改革委, 工业和信息化部, 等. 关于开 展国家组织高值医用耗材集中带量采购和使用的指导意 见[EB/OL]. (2021-06-04)[2024-10-23]. https://www.nhsa.gov. cn/art/2021/6/4/art_37_5208.html.
[14] 潘倩莹, 熊康, 陈昊. 药品和耗材跨区域带量采购的实践与 思考[J]. 中国卫生资源, 2021, 24(2): 119-122.
[15] 明坚, 胡善联. 不同品牌经外周静脉穿刺置入中心静脉导管临 床使用的成本分析比较[J]. 中国药物经济学, 2022, 17(8): 32-38.
Ming J, Hu SL. Cost analysis of different peripherally inserted central catheters in clinical settings[J]. China J Pharm Econ, 2022, 17(8): 32-38.
[16] 王艳瑞. 巴德PICC和贝朗PICC临床应用不良事件对比分析[J]. 全科口腔医学杂志(电子版), 2019, 6(1): 118.
[17] Matza LS, Murray LT, Phillips GA, et al. Qualitative research on fatigue associated with depression: content validity of the fatigue associated with depression questionnaire (FAsD-V2)[J]. Patient, 2015, 8(5): 433-443.
[18] 严加洁, 何金爱, 黄果花, 等. 经外周静脉留置中心静脉导管术 学习曲线的前瞻性研究[J]. 护士进修杂志, 2015, 30(2): 100-103.
Yan JJ, He JA, Huang GH, et al. The prospective study of learning curves for peripherally inserted central venous catheter[J]. J Nurses Train, 2015, 30(2): 100-103.
[19] 边斯洁, 夏锋, 夏燕, 等. 浙江省冠脉支架集中带量采购政策对 住院患者费用的影响研究[J]. 中国医院管理, 2024, 44(1): 36-38.
Bian SJ, Xia F, Xia Y, et al. Impact of the policy of centralized purchase of coronary stents in Zhejiang Province on the cost of inpatients[J]. Chin Hosp Manag, 2024, 44(1): 36-38.
[20] 艾阳, 李必龙, 朱春甲, 等. 低剂量利伐沙班在老年非瓣膜性房 颤治疗中的效果观察[J]. 实用老年医学, 2020, 34(7): 666-669.
Ai Y, Li BL, Zhu CJ, et al. Observation of low dose rivaroxaban in the treatment of non-valvular atrial fibrillation in elderly[J]. Pract Geriatr, 2020, 34(7): 666-669.
[21] 李和杏, 李佩兰, 李美容, 等. 隧道式Power PICC置管在降低 肿瘤患者导管相关并发症发生率中的应用效果[J]. 当代医药 论丛, 2023, 21(2): 194-196.
[22] 明坚, 王宇, 李幸蓉, 等. 带量采购前后不同静脉留置针的临床 使用情况及费用比较[J]. 中国卫生资源, 2021, 24(2): 126-130.
[23] 周广进, 常峰, 路云. 心脏起搏器类高值医用耗材省级带量 采购现状分析[J]. 中国卫生经济, 2023, 42(9): 16-19.
Zhou GJ, Chang F, Lu Y. Comparative analysis on the current provincial procurement of high-value medical consumables for cardiac pace-makers[J]. Chin Health Econ, 2023, 42(9): 16-19.
[24] 梅国江, 沈磊, 向寰宇. 基于真实世界证据的冠脉支架集采前 后临床使用效果研究[J]. 中国医疗设备, 2023, 38(10): 126-130.
Mei GJ, Shen L, Xiang HY. Clinical effect of coronary stents before and after centralized volume-based procurement based on real-world evidence[J]. China Med Devices, 2023, 38(10): 126-130.

基金

国家卫健委医院管理研究所基于真实世界证据的聚氨酯材质PICC导管带量采购后临床应用评价研究(20230646)。

PDF(1655 KB)

80

Accesses

0

Citation

Detail

段落导航
相关文章

/